CX-188
- Generic Name
- CX-188
PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- CytomX Therapeutics
- Registration Number
- NCT03706274
- Locations
- 🇺🇸
Virginia Cancer Specialists, Fairfax, Virginia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath